David Joyner
President and Chief Executive Officer
Legacy
David Joyner was appointed CEO in October 2024 following the departure of Karen Lynch amid CVS Health's Medicare Advantage underwriting crisis. A longtime CVS Health executive and Caremark specialist, Joyner brings deep operational knowledge of the company's PBM operations and a reputation for financial discipline that the board deemed essential for the current period of strategic recalibration. Joyner has signaled a strategic shift away from headline acquisitions toward operational integration of existing assets, with particular emphasis on demonstrating measurable clinical and financial outcomes from the company's integrated model. His appointment reflects a board-level judgment that CVS's near-term priority is restoring investor confidence through disciplined execution rather than ambitious expansion.